Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: The RAWD model

ClinicoEconomics and Outcomes Research

Volumn 4, Issue 1, 2012, Pages 109-116

  Rautenberg, Tamlyn Anne ^a,b   Zerwes, Ute ^a   Foerster, Douglas ^c,d   Aultman, Rick ^e  

^a Assessment in Medicine GmbH   (Germany)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ABBOTT LABORATORIES   (United States)

^d BIELEFELD UNIVERSITY   (Germany)

^e Semalytics   (United States)

Author keywords

Acute watery diarrhea; Cost effectiveness; Health economic model; Infant; QALY; Racecadotril

Indexed keywords

ACETORPHAN; LOPERAMIDE; ORAL REHYDRATION SOLUTION; PLACEBO;

ACUTE DIARRHEA; ACUTE WATERY DIARRHEA; ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER PROGRAM; CONSULTATION; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION TREE; DRUG COST; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; ECONOMIC EVALUATION; HUMAN; META ANALYSIS (TOPIC); MONOTHERAPY; MONTE CARLO METHOD; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; UNITED KINGDOM; URTICARIA; VOMITING;

EID: 84930482235     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S31238     Document Type: Article

References (43)

1. World Gastroenterology Organisation (WGO). World Gastroenterology Organisation practice guideline: Acute diarrhea. 2008. Available from: http://www.omge.org/assets/downloads/en/pdf/guidelines/01_acute_ diarrhea.pdf. Accessed on August 12, 2011.
2. National Collaborating Centre for Women's and Children's Health (NCCWCH). Diarrhoea and vomiting diagnosis, assessment and management in children younger than 5 years caused by gastroenteritis. 2009.
3. Lecomte JM. An overview of clinical studies with racecadotril in adults. Int J Antimicrob Agents. 2000;14(1):81-87.
4. Farthing MJ. Antisecretory drugs for diarrheal disease. Dig Dis. 2006; 24(1-2):47-58.
5. Spillantini MG, Geppetti P, Fanciullacci M, Michelacci S, Lecomte JM, Sicuteri F. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol. 1986;125(1):147-150.
6. Knisely JS, Beardsley PM, Aceto MD, Balster RL, Harris LS. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor. Drug Alcohol Depend. 1989;23(2):143-151.
7. Duval-Iflah Y, Berard H, Baumer P, et al. Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet. Aliment Pharmacol Ther. 1999; 13(Suppl 6):9-14.
8. Cezard JP, Duhamel JF, Meyer M, et al. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology. 2001;120(4): 799-805.
9. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med. 2000;343(7):463-467.
10. Savita MR, Mysore GMC. Racecadotril-a novel drug for the treatment of acute watery diarrhea in Indian children. 2nd Pediatric Infectious Diseases Conference 2006. Available from: http://www.pediatriconcall. com/fordoctor/conference_abstracts/racecadotrial.asp. Accessed on September 2, 2011.
11. Cojocaru B, Bocquet N, Timsit S, et al. Effect of racecadotril in the management of acute diarrhea in infants and children. Arch Pediatr. 2002;9(8):774-779.
12. Santos M, Maranon R, Miguez C, Vazquez P, Sanchez C. Use of racecadotril as outpatient treatment for acute gastroenteritis: a prospective, randomized, parallel study. J Pediatr. 2009;155(1):62-67.
13. Alvarez Calatayud E, Pinei Simon G, Taboada Castro L, et al. Efectividad de racecadotrilo en el tratamiento de la gastroenteritis aguda [The effectiveness of racecadotril in the treatment of acute gastroenteritis.]. Acta Pediatr Esp. 2009;67(3):117-122.
14. Gutierrez-Castrellon P, Acosta-Bastidas M, Llamosas Gallardo B, et al. Ensayo clinico aleatorizado y analisis farmacoeconomico del impacto de racecadotrilo (Hidrasec) como coadyuvante en el tratamiento de la gastroenetritis aguda sobre la reduccion de los gastos hospitalierios relacionados en lactantes menores de 24 meses en Mexico. Rev Invest Clin. 2011. In press.
15. Melendez Garcia JM, Rodriguez JT. Racecadotril en el tratamiento de la diarrea agudo en ninos. Rev Facultad Med (Guatemala). 2007;4: 25-28.
16. Szajewska H, Ruszczynski M, Chmielewska A, Wieczorek J. Systematic review: racecadotril in the treatment of acute diarrhoea in children. Aliment Pharmacol Ther. 2007;26(6):807-813.
17. Emparanza Knörr JI, Ozcoidi Erro I, Martínez Andueza MC, Callén Blecua MT, Alústiza Martínez E, Aseguinolaza Iparraguirre I. Revisión sistemática sobre la eficacia de racecadotrilo en el tratamiento de la diarrea aguda [Systematic review of the efficacy of racecadotril in the treatment of acute diarrhea.] An Pediatr (Barc). 2008;69(5): 432-438.
18. Hao R, De Vera M, Resurreccion E. Racecadotril in the treatment of acute diarrhea in children: a meta-analysis. PIDSP Journal 2010;11(2): 19-32.
19. Lehert P, Cheron G, Calatayud GA, et al. Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis. Dig Liver Dis. 2011;43(9):707-713.
20. Baumer P, Joulin Y. Pre-and postmarketing safety prof iles of Racecadotril sachets, a "new" antidiarrhoeal drug. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 3):E99.
21. Turck D, Berard H, Fretault N, Lecomte JM. Comparison of racecadotril and loperamide in children with acute diarrhoea. Aliment Pharmacol Ther. 1999;13(Suppl 6):27-32.
22. Hall S. Expert Interview Primary Care Physician United Kingdom. 13-11-2012.
23. Silver L. Expert Interview Primary Care Physician United Kingdom. 13-12-2011.
24. World Health Organization (WHO). The treatment of diarrhoea-A manual for physicians and other senior health workers. 2005. Available from: http://www.who.int/maternal_child_adolescent/ documents/9241593180/en/. Accessed on February 16, 2012.
25. Chacon J. Analysis of factors influencing the overall effect of racecadotril on childhood acute diarrhea. Results from a real-world and post-authorization surveillance study in Venezuela. Ther Clin Risk Manag. 2010;6:293-299.
26. Huppertz HI, Forster J, Heininger U, Roos R, Neumann HU, Hammerschmidt T. The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila). 2008;47(4): 363-371.
27. Brisson M, Senecal M, Drolet M, Mansi JA. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J. 2010;29(1):73-75.
28. Martin A, Cottrell S, Standaert B. Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK. J Med Econ. 2008;11(3):471-484.
29. Goossens LM, Standaert B, Hartwig N, Hovels AM, Al MJ. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine. 2008;26(8):1118-1127.
30. World Health Organization (WHO). The WHO Child Growth Standards. 2012. Available from: http://www.who.int/childgrowth/en/. Accessed on February 16, 2012.
31. Buzzle com. Average Weight for Children by Age. 2012. Available from: http://www.buzzle.com/articles/average-weight-for-childrenby-age.html. Accessed on February 16, 2012.
32. Royal College of Paediatrics and Child Health (RCPCH). UK-WHO growth charts. 2012. Available from: http://www.rcpch.ac.uk/Research/ UK-WHO-Growth-Charts. Accessed on February 16, 2012.
33. World Health Organization (WHO). Growth reference data for 5-19 years. 2012. Available from: http://www.who.int/growthref/en/. Accessed on February 16, 2012.
34. Joint Formulary Committee. British National Formulary; 2008.
35. Abbott Products Operations AG. United Kingdom Drug Cost Estimate. 2012.
36. Personal Social Services Research Unit. Unit Costs of Health and Social Care 2010 PSSRU. Personal Social Services Research Unit Kent; 2010.
37. Primary diagnosis: summary. Hospital Episodes Statistics-HESonline 2012; Available from: http://www.hesonline.nhs.uk/Ease/servlet/Con tentServer?siteID=1937&categoryID=202. Accessed on February 16, 2012.
38. Healthcare Resource Groups. Hospital Episodes Statistics-HESonline 2012. Available from: URL: http://www.hesonline.nhs.uk/Ease/servlet/ ContentServer?siteID =1937&categoryID=206. Accessed on February 16, 2012.
39. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D, Discussion Paper 172. Centre for Health Economics York University; 1999.
40. National Institute for Health and Clinical Excellence (NICE). Costing statement: diarrhoea and vomiting in children; 2009.
41. Cegedim Strategic Data UK Limited. Cegedim Strategic Data; 2011.
42. Koletzko S, Osterrieder S. Acute infectious diarrhea in children. Dtsch Arztebl Int. 2009;106(33):539-547.
43. Van der Wielen M, Giaquinto C, Gothefors L, et al. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract. 2010;11:22.